Get started
Author

Françoise Grudé

Observed names: F Grude, F Grudé, F R Grude, F. Grude, F. Grudé, F. Grudé, Francoise Grude, Francoise Grudé, Grude, Françoise, Grudé, Françoise
Observed institutions: Université Européenne de Bretagne, Institut Gustave Roussy, Institut de Cancérologie de l'Ouest, Agence Nationale de Sécurité du Médicament et des Produits de Santé, Centre Eugène Marquis, Centre hospitalier Bretagne Atlantique, Centre Jean Bernard, Centre Hospitalier privé Saint Grégoire, Centre Hospitalier Régional Universitaire de Brest, Clinique Victor Hugo, National Cancer Center Hospital East, Institut Paoli-Calmettes, Centre Hospitalier des Pays de Morlaix, Université d'Angers
OpenAlex ID: A5083552624
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
2017 · H. Bourgeois, F. Grudé, et al. · Annals of Oncology · 54
PANERB study: Panitumumab after cetuximab-based regimen failure.
2010 · J. Metges, J. Raoul, et al. · Journal of Clinical Oncology · 38
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
2021 · Emmanuelle Jacquet, Ghania Kerouani-Lafaye, et al. · European Journal of Cancer · 21
PDF
Efficacy and safety of FOLFIRINOX in patients with metastatic pancreatic cancer.
2014 · Jean Philippe Metges, Jean François Ramée, et al. · Journal of Clinical Oncology · 14
Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019
2022 · Fiona Y.‐V. Pham, Emmanuelle Jacquet, et al. · International Journal of Cancer · 11
Early access to health products in France: Major advances of the French “Conseil stratégique des industries de santé” (CSIS) to be implemented (modalities, regulations, funding)
2018 · Nicolas Albin, Frédéric Chassagnol, et al. · Therapies · 11
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients
2019 · Eric Voog, Boris Campillo‐Gimenez, et al. · International Journal of Cancer · 10
PDF
Access to innovation through the national early access program and clinical trials for patients with malignant melanoma
2021 · Claire Christen, Laetitia Belgodère, et al. · Cancer · 9
Impact of anti-infectious and corticosteroids on immunotherapy: Nivolumab and pembrolizumab follow-up in a French study
2018 · J.-P. Metges, E. Michaud, et al. · Annals of Oncology · 9
Prise en charge des patients sous voies orales anticancéreuses au domicile en Bretagne et Pays de la Loire : enquête fin 2016 et cartographie
2019 · Françoise Grudé, Fanny Marhuenda, et al. · Bulletin du Cancer · 7
Long Term Persistent Alopecia and Suboptimal Hair Regrowth after Adjuvant Chemotherapy for Breast Cancer: Alert for an Emerging Side Effect: ALOPERS Observatory.
2009 · H. Bourgeois, F. Denis, et al. · Cancer Research · 7
Impact of anti-infectious and corticosteroids on immunotherapy: Nivolumab and pembrozilumab follow-up in a French study.
2018 · Jean-Philippe Metges, Emmanuelle Michaud, et al. · Journal of Clinical Oncology · 5
Anticorps monoclonaux à usage thérapeutique : spécificités du développement clinique, évaluation par les agences, suivi de la tolérance à long terme
2012 · Gilles Paintaud, Marine Diviné, et al. · Therapies · 5
Accès précoce aux produits de santé en France : des avancées majeures du CSIS (Conseil stratégique des industries de santé) à concrétiser (modalités, réglementations, financements)
2018 · Nicolas Albin, Frédéric Chassagnol, et al. · Therapies · 4
Bevacizumab and irinotecan in patients with recurrent glioblastoma (GBM): Results of a retrospective cohort study of the OMIT Bretagne and Pays de la Loire.
2011 · F. Grude, M. Campone, et al. · Journal of Clinical Oncology · 4
Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post–EMA-approval descriptive study with a geriatric oncology focus
2020 · Jean-Philippe Metges, Jean-Yves Douillard, et al. · The Turkish Journal of Gastroenterology · 3
PDF
Panerb Study: Which Category of Patients, Suffering from Metastatic Colorectal Cancer, Can Benefit From Panitumumab Treatment After Cetuximab-Based Regimen Failure?
2012 · J. Metges, J.F. Ramée, et al. · Annals of Oncology · 3
PDF
Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety
2012 · Gilles Paintaud, Marine Diviné, et al. · Therapies · 3
What is the benefit for patients suffering from metastatic colorectal cancer (mCRC) after bevacizumab-based regimen (BBR), cetuximab-based regimen (CBR), and panitumumab (P)?
2011 · J. Metges, J. Ramée, et al. · Journal of Clinical Oncology · 3
Knowledge of geriatric oncology in nursing homes: survey among healthcare professionals working in nursing homes in Pays-de-la-Loire.
2021 · Marianne Le Rhun, Véronique Bourcy, et al. · Gériatrie et Psychologie Neuropsychiatrie du Viellissement · 2
PDF
L’état vaccinal des sujets âgés atteints de cancer recevant une chimiothérapie : rappel des recommandations et zoom sur la région Bretagne
2018 · H. Fronteau, V. Jestin Le Tallec, et al. · ONCOLOGIE · 2
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics
2014 · J. P. Metges, M. A. Lebot, et al. · ONCOLOGIE · 2
PDF
Optimisation du bon usage et maîtrise des coûts des médicaments anticancéreux : expérience de l’Observatoire dédié au Cancer Bretagne – Pays-de-la-Loire
2013 · Françoise Grudé, Réjane Bessard, et al. · Bulletin du Cancer · 2
Efficacy and safety of FOLFIRINOX in patients with pancreatic metastatic cancer.
2013 · Jean-Philippe Metges, Jean François Ramée, et al. · Journal of Clinical Oncology · 2
Abstract OT3-3-04: ALOPREV: first cooling scalp trial for prevention of persisting alopecia after docetaxel for early breast cancer patients.
2012 · H Bourgeois, P Soulié, et al. · Cancer Research · 2
Works count: 67
Citation count: 248
H-index: 9
I10-index: 7
Year
Topic
Type